ASND · ISSUER CIK 1612042
Ascendis Pharma A/S
Between Aug 1, 2026 and Oct 29, 2026, 3 Ascendis Pharma A/S insiders reported $493K of open-market purchases and $873K of sales on SEC Form 4. The largest buyer was Bienaime Jean Jacques (Director), with $493K.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$493KInsider buying
$873KInsider selling
−$380KNet open-market
Sep 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202617:04 | Sep 8, 2026 | ASND | SVP & PAO | S · Sell | $270.19 | −3,000 | 0 | -100% | −$811K | ||
| Sep 9, 202617:04 | Sep 8, 2026 | ASND | SVP & PAO | M · Exercise | $110.00 | +3,000 | 3,000 | New | $330K | ||
| Sep 3, 202616:09 | Sep 2, 2026 | ASND | Director | S · Sell | $264.13 | −236 | 4,000 | -6% | −$62K | ||
| Aug 18, 202621:02 | Aug 14, 2026 | ASND | Director | P · Buy | $246.33 | +2,000 | 2,900 | +222% | +$493K | -11.1% | +2.7% |